TNF and Cognitive impairment: The findings of the present study suggest that BML-111 markedly decreases the levels of inflammatory cytokines without changing the level of TNF-α in the blood, and also reduces the activation of glias, the number of TUNEL-positive cells, and cognitive impairment in the brains during sepsis.